BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24280701)

  • 21. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.
    He H; Sun L; Ye J; Liu E; Chen S; Liang Q; Shin MC; Yang VC
    J Control Release; 2016 Oct; 240():67-76. PubMed ID: 26514292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.
    Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X
    Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C; Nielsen HM
    Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.
    Shi NQ; Li Y; Zhang Y; Shen N; Qi L; Wang SR; Qi XR
    ACS Appl Mater Interfaces; 2017 Dec; 9(48):41767-41781. PubMed ID: 29161013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.
    Bolhassani A
    Biochim Biophys Acta; 2011 Dec; 1816(2):232-46. PubMed ID: 21840374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory Drugs.
    Hingorani DV; Camargo MF; Quraishi MA; Adams SR; Advani SJ
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33801967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.
    Bidwell GL; Raucher D
    Adv Drug Deliv Rev; 2010 Dec; 62(15):1486-96. PubMed ID: 20478348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
    Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
    Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
    Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
    Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
    Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
    Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics.
    Ryu JS; Kuna M; Raucher D
    Ther Deliv; 2014 Apr; 5(4):429-45. PubMed ID: 24856169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocytosis, intracellular traffic and fate of cell penetrating peptide based conjugates and nanoparticles.
    Cleal K; He L; Watson PD; Jones AT
    Curr Pharm Des; 2013; 19(16):2878-94. PubMed ID: 23140451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria.
    Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO
    Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
    Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
    Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies.
    Anwar S; Mir F; Yokota T
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smart Cell-Penetrating Peptide-Based Techniques for Intracellular Delivery of Therapeutic Macromolecules.
    He Y; Li F; Huang Y
    Adv Protein Chem Struct Biol; 2018; 112():183-220. PubMed ID: 29680237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Lung Targeting Cell Penetrating Peptides as Vectors for Delivery of Therapeutics.
    McCandless K; Mishra S; Stiltner J; Feldman KS; Yagi H; Yurko R; Islam K; Brown JM; Frizzell R; Zahid M
    Res Sq; 2021 Nov; ():. PubMed ID: 34816257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-Penetrating Peptides as a Potential Drug Delivery System for Effective Treatment of Diabetes.
    Korivi M; Huang YW; Liu BR
    Curr Pharm Des; 2021; 27(6):816-825. PubMed ID: 33076803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective Uptake Into Drug Resistant Mammalian Cancer by Cell Penetrating Peptide-Mediated Delivery.
    Carnevale KJF; Muroski ME; Vakil PN; Foley ME; Laufersky G; Kenworthy R; Zorio DAR; Morgan TJ; Levenson CW; Strouse GF
    Bioconjug Chem; 2018 Oct; 29(10):3273-3284. PubMed ID: 30240193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.